Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer
(Q60152330)
Language:
Current Data About
Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer
| (P31) |
(Q13442814)
|
||||||||||||||||||||
| (P50) |
(Q7609399)
(Q107303606)
(Q107303631)
(Q107303778)
(Q107311719)
|
||||||||||||||||||||
| (P577) |
Monday, June 14, 2004
|
||||||||||||||||||||
| (P921) |
(Q5452194)
|
||||||||||||||||||||
| (P1433) |
(Q7247172)
|
||||||||||||||||||||
| (P1476) |
"Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer" (language: en)
|
||||||||||||||||||||
| (P2093) |
Diana C. H. Stripp
Timothy C. Zhu
Richard Whittington
Debbie Smith
Jeremy Miles
Theresa M. Busch
Daniel Shin
Alex Kachur
Zelig A. Tochner
S. Bruce Malkowicz
|
other details